Skip to main content
. 2020 Nov 18;13:557. doi: 10.1186/s13071-020-04411-9

Fig. 3.

Fig. 3

Schistosoma haematobium infection status by treatment group from baseline to Year 5 (9–12 year-olds cross-section only). The change in overall prevalence of S. haematobium infection over time from the start of the project at baseline to the final Year 5 by treatment group among the 9–12 year-old age group only is shown